[1]
M. Karimi and V. De Sanctis, “Implications of SARSr-CoV 2 infection in thalassemias: Do patients fall into the ‘high clinical risk’ category?”, Acta Bio Med, vol. 91, no. 2, pp. 50-56, May 2020.